CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −7,470 | $302.74 | $2.3M | 10,343 |
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,633 | $303.13 | $495K | 8,710 |
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,442 | $303.72 | $1.7M | 3,268 |
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,255 | $304.13 | $382K | 2,013 |
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,973 | $304.36 | $601K | 40 |
| 2025-12-16 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −40 | $305.24 | $12K | 0 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,791 | $301.58 | $540K | 98,209 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −6,389 | $302.29 | $1.9M | 91,820 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,896 | $303.60 | $576K | 89,924 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,829 | $304.37 | $1.8M | 84,095 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −3,940 | $305.55 | $1.2M | 80,155 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −4,949 | $306.39 | $1.5M | 75,206 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,118 | $307.38 | $1.6M | 70,088 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −14,163 | $308.41 | $4.4M | 55,925 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −10,650 | $309.37 | $3.3M | 45,275 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −16,318 | $310.48 | $5.1M | 28,957 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,344 | $311.33 | $730K | 26,613 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −121 | $311.93 | $38K | 26,492 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −929 | $313.52 | $291K | 25,563 |
| 2025-12-15 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,194 | $314.92 | $376K | 24,369 |
Page 16 of 71 · 1,406 trades